XML 38 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents the segment loss, including significant segment expenses, for the three and nine months ended September 30, 2025 and 2024:
Three Months Ended September 30,
Nine Months Ended September 30,
2025202420252024
(In thousands)
License revenue
$— $1,000 $— $1,000 
Operating expenses
Compensation and benefits$15,801 $13,081 $48,139 $41,010 
Clinical trial and manufacturing
21,559 6,334 51,239 14,172 
Facilities and IT
3,481 9,563 21,274 26,125 
Other research and development2,125 1,572 7,083 3,298 
Other segment(a)
5,057 4,888 18,364 12,936 
Total operating expenses$48,023 $35,438 $146,099 $97,541 
Operating loss(48,023)(34,438)(146,099)(96,541)
Other income, net
371 2,087 2,237 6,545 
Segment and consolidated net loss$(47,652)$(32,351)$(143,862)$(89,996)
(a)
Other segment include professional services, consultants and contractors, travel and entertainment expenses, and general business expenses.